Circulating ghrelin and ghrelin to obestatin ratio are low in patients with untreated mild-to-moderate hypertension

Regulatory Peptides

Volumn 165, Issue 2-3, 2010, Pages 206-209

  Li, Zhao Feng ^a   Guo, Zhi Fu ^b   Yang, Shu Guang ^a   Zheng, Xing ^b   Cao, Jiang ^b   Qin, Yong Wen ^b  

^a No 88 Hospital of PLA   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Blood pressure; Ghrelin; Hypertension; Obestatin

Indexed keywords

GHRELIN; OBESTATIN; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE SEVERITY; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; MODERATE HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTHROPOMETRY; FASTING; GHRELIN; HUMANS; HYPERTENSION; MALE;

EID: 78649853748     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.07.168     Document Type: Article

References (19)

1. Anderwald-Stadler M., Krebs M., Promintzer M., Mandl M., Bischof M.G., Nowotny P., et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 2007, 293:E1393-E1398.
2. Akamizu T., Murayama T., Teramukai S., MuIUra K., Bando I., Irako T., et al. Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in elderly females correlate positively with serum IGF-I levels and bowel movement frequency and negatively with systolic blood pressure. J Endocrinol 2006, 188:333-344.
3. Chen C., Lu F.C. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 2004, 17:1-36.
4. Guo Z.F., Zheng X., Qin Y.W., Hu J.Q., Chen S.P., Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 2007, 92:1875-1880.
5. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kagawa K. Ghrelin is a growth-hormone-releasing acylated peptides from stomach. Nature 1999, 402:656-660.
6. Lin Y., Matsumura K., Fukuhara M., Kagiyama S., Fujii K., Iida M. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension 2004, 43:977-982.
7. Li Z.F., Guo Z.F., Cao J., Hu J.Q., Zhao X.X., Xu R.L., et al. Plasma ghrelin and obestatin levels are increased in spontaneously hypertensive rats. Peptides 2010, 31:297-300.
8. Li Z.F., Song S.W., Qin Y.W., Zhang J.L., Zhao X.X., Zhang B.L., et al. Bolus intravenous injection of obestatin does not change blood pressure level of spontaneously hypertensive rat. Peptides 2009, 30:1928-1930.
9. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
10. Matsumura K., Tsuchihashi T., Fujii K., Abe I., Iida M. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 2002, 40:694-699.
11. Makino Y., Hosoda H., Shibata K., Makino I., Kojima M., Kangawa K., et al. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 2002, 39:781-784.
12. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1483-R1487.
13. Okumura H., Nagaya N., Enomoto M., Nakagawa E., Oya H., Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 2002, 39:779-783.
14. Pöykkö S.M., Kellokoski E., Hörkkö S., Kauma H., Kesäniemi Y.A., Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003, 52:2546-2553.
15. Ren A.J., He Q., Shi J.S., Guo Z.F., Zheng X., Lin L., et al. Association of obestatin with blood pressure in the third trimesters of pregnancy. Peptides 2009, 30:1742-1745.
16. Soares J.B., Leite-Moreira A.F. Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 2008, 29:1255-1270.
17. Shinde U.A., Desai K.M., Yu C., Gopalakrishnan V. Nitric oxide synthase inhibition exaggerates the hypotensive response to ghrelin: role of calcium-activated potassium channels. J Hypertens 2005, 23:779-784.
18. Wiley K.E., Davenport A.P. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 2002, 136:1146-1152.
19. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.